Anthony S. Gibney is EVP & Chief Business Officer at Aura Biosciences, Inc. (AURA). They have made 5 open-market trades across 3 companies since 2022, most recently 2026-06-16.
CIK 0001750132
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $620K since 2024, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AURA | 265,354 | $1.6M |
| ISEE | 40,291 | $1.6M |
| CLSD | 6,710 | $3K |
| Total | $3.2M |
Shares reported on the most recent Form 4, priced at the 2026-06-16 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AURA | SELL | 2026-06-16 | 2026-06-16 | $6.42 | $82K | +6.0% | +6.3% | +8.2% |
| AURA | BUY | 2025-05-16 | 2025-05-20 | $4.90 | $490K | -0.8% | -2.7% | +7.7% |
| AURA | SELL | 2025-05-16 | 2025-05-20 | $5.15 | $8K | -0.8% | -2.7% | +7.7% |
| CLSD | BUY | 2024-04-17 | 2024-04-19 | $1.30 | $130K | -3.1% | +1.5% | -12.2% |
| ISEE | SELL | 2022-07-05 | 2022-07-05 | $9.41 | $147K | +16.5% | +20.8% | +81.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.